Back
Innate Pharma SA Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
IPHA
Innate Pharma SA
Last Price:
$1.71
Seasonality Move:
12.9%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing slight selling pressure.
Innate Pharma SA Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.8 | Sell |
| 20-day SMA: | 1.86 | Sell |
| 50-day SMA: | 1.94 | Sell |
| 200-day SMA: | 1.99 | Sell |
| 8-day EMA: | 1.79 | Sell |
| 20-day EMA: | 1.84 | Sell |
| 50-day EMA: | 1.87 | Sell |
| 200-day EMA: | 1.27 | Buy |
Innate Pharma SA Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 35.4 | Sell |
| Chaikin Money Flow: | -7484 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.79 - 1.91) | Sell |
| Bollinger Bands (100): | (1.85 - 2.15) | Sell |
Innate Pharma SA Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Innate Pharma SA Stock
Is Innate Pharma SA Stock a Buy?
-
Innate Pharma SA share price is 1.70 while IPHA 8-day simple moving average is 1.80, which is a Sell signal.
-
The stock price of IPHA is 1.70 while Innate Pharma SA 20-day SMA is 1.86, which makes it a Sell.
-
Innate Pharma SA 50-day simple moving average is 1.94 while IPHA share price is 1.70, making it a Sell technically.
-
IPHA stock price is 1.70 and Innate Pharma SA 200-day simple moving average is 1.99, creating a Sell signal.
IPHA Technical Analysis vs Fundamental Analysis
Sell
40
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy or a Sell?
-
Innate Pharma SA stock is rated a SellThe current Innate Pharma SA [IPHA] share price is $1.70. The Score for IPHA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Innate Pharma SA Stock Info
Market Cap:
156.7M
Price in USD:
1.70
Share Volume:
37.4K
Innate Pharma SA 52-Week Range
52-Week High:
2.63
52-Week Low:
1.60
Sell
40
Innate Pharma SA (IPHA)
is a Sell
Innate Pharma SA Share Price Forecast
-
What is the Innate Pharma SA stock price today?The Innate Pharma SA stock price is 1.70 USD today.
-
Will IPHA stock go up or go down?Innate Pharma SA> share price is forecast to RISE/FALL based on technical indicators
-
Is Innate Pharma SA overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Innate Pharma SA is overvalued.
Is Innate Pharma SA Stock a Buy?
-
Innate Pharma SA share price is 1.70 while IPHA 8-day exponential moving average is 1.79, which is a Sell signal.
-
The stock price of IPHA is 1.70 while Innate Pharma SA 20-day EMA is 1.84, which makes it a Sell.
-
Innate Pharma SA 50-day exponential moving average is 1.87 while IPHA share price is 1.70, making it a Sell technically.
-
IPHA stock price is 1.70 and Innate Pharma SA 200-day simple moving average is 1.27, creating a Buy signal.
Fundamental Analysis of Innate Pharma SA
Is Innate Pharma SA a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.04 per share.
Technical Analysis of Innate Pharma SA
Should I short Innate Pharma SA stock?
-
IPHA Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Innate Pharma SA is a Sell
-
Innate Pharma SA Relative Strength Index (RSI) is 35.4, which suggest Innate Pharma SA is oversold
-
The Bollinger Bands (25) for Innate Pharma SA is (1.79 - 1.91), which suggest Innate Pharma SA is a Sell
-
The Bollinger Bands (100) for Innate Pharma SA is (1.85 - 2.15), which suggest Innate Pharma SA is a Sell
* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.